Please email a PDF of the following article: This House believes that the UK healthcare system may be failing as many as 50% of patients with hyperlipidaemia by not reducing their cholesterol to effective
levels: a debate A panel of experts, sponsored by Merck Sharp & Dohme Ltd and Schering-Plough Ltd and made up of cardiologists, lipidologists, general practitioners and nurses with a special interest in coronary heart disease and lipid management, met recently to debate whether individuals with hyperlipidaemia are being treated to effective levels and, if not, how current and future treatment options could be better employed to reduce cardiovascular risk.
